Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency: primary endpoint results, effect estimate with confidence interval,…
- Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DoDNACIndependent statistical analysis of Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04481048).
- Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?: Complete Statistical AnalysisIndependent statistical analysis of Does a Patient Education Video Augment Pelvic Floor Physical Therapy Compliance?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?: Complete Statistical AnalysisIndependent statistical analysis of Does Acute Oxytocin Administration Enhance Social Cognition in Individuals With Schizophrenia?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?: Complete Statistical AnalysisIndependent statistical analysis of Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?: Complete Statistical AnalysisIndependent statistical analysis of Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement: Complete Statistical AnalysisIndependent statistical analysis of Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?: Complete Statistical AnalysisIndependent statistical analysis of Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: Complete Statistical AnalysisIndependent statistical analysis of Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Patients With Acute Sickle Cell Crises?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does IV Ondansetron Prevent Pruritus After Intrathecal Morphine in Pediatric Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does More Practice Improve Arm Movement After Stroke?: Complete Statistical AnalysisIndependent statistical analysis of Does More Practice Improve Arm Movement After Stroke?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01146379).
- Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?: Complete Statistical AnalysisIndependent statistical analysis of Does Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults Enhance Parenting Performance?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?: Complete Statistical AnalysisIndependent statistical analysis of Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01040819).
- Does Rosuvastatin Delay Progression of Atherosclerosis in HIV: Complete Statistical AnalysisIndependent statistical analysis of Does Rosuvastatin Delay Progression of Atherosclerosis in HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01813357).
- Does Social Buffering Continue to be Effective Over the Peripubertal Period When Friends Share the Stressor Experience?: Complete Statistical AnalysisIndependent statistical analysis of Does Social Buffering Continue to be Effective Over the Peripubertal Period When Friends Share the Stressor Experience?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers: Complete Statistical AnalysisIndependent statistical analysis of Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?: Complete Statistical AnalysisIndependent statistical analysis of Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?: primary endpoint…
- Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?: Complete Statistical AnalysisIndependent statistical analysis of Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: Complete Statistical AnalysisIndependent statistical analysis of Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Does Ultrasound Improve Procedural Time in the Lateral Popliteal Approach to the Sciatic Nerve in Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Does Ultrasound Improve Procedural Time in the Lateral Popliteal Approach to the Sciatic Nerve in Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DolphinIndependent statistical analysis of A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB): primary endpoint results, effect estimate with confidence…
- Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval,…
- Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults: primary endpoint results, effect estimate with confidence…
- Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors: Complete Statistical AnalysisIndependent statistical analysis of Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DOPAACRO 002Independent statistical analysis of Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DORAVIPEPIndependent statistical analysis of Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study: primary endpoint results, effect…
- Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals: Complete Statistical AnalysisIndependent statistical analysis of Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): Complete Statistical AnalysisIndependent statistical analysis of Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DORNASESARS2Independent statistical analysis of Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer: primary endpoint results, effect estimate with confidence interval,…
- Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01976741).
- Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC): Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC): primary endpoint results, effect estimate with confidence…
- Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001): Complete Statistical AnalysisIndependent statistical analysis of Dose Evaluation of MK-1966 in Combination With SD-101 in Participants With Advanced Malignancies (MK-1966-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis: Complete Statistical AnalysisIndependent statistical analysis of Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…